Dass Gastroentrology & Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.31 Cr
- Revenue Growth 515.57%
- Profit Growth 170.62%
- Ebitda 132.99%
- Net Worth 90.43%
- Total Assets 16.45%
About Dass Gastroentrology & Research
Dass Gastroentrology & Research Private Limited (DGRPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 December 2021 (Three years and two months 12 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.31 Cr.
Ameet Banka, Sanjeev Kumar, and Sanjeev Thakur serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100BR2021PTC055561
- Company No.
055561
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Dass Gastroentrology & Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ameet Banka  | Director | 14-Dec-2021 | Current |
| Sanjeev Kumar | Director | 14-Dec-2021 | Current |
| Sanjeev Thakur | Director | 14-Dec-2021 | Current |
Financial Performance of Dass Gastroentrology & Research.
Dass Gastroentrology & Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 515.57% increase. The company also saw a substantial improvement in profitability, with a 170.62% increase in profit. The company's net worth Soared by an impressive increase of 90.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dass Gastroentrology & Research?
Unlock access to Dass Gastroentrology & Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹13.08 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2023 | Hdfc Bank Limited | ₹1.31 Cr | Open |
How Many Employees Work at Dass Gastroentrology & Research?
Dass Gastroentrology & Research has a workforce of 0 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dass Gastroentrology & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dass Gastroentrology & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.